Cambridge Investment Research Advisors’s abrdn Healthcare Investors HQH Stock Holding History

Cambridge Investment Research Advisors’s Portfolio HQH Stock Details HQH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.92M	Buy	87,280 +4,629	+6%	+$91.2K	﹤0.01%	1602
2026 Q1	$1.47M	Buy	82,651 +3,134	+4%	+$59.3K	﹤0.01%	1848
2025 Q4	$1.51M	Sell	79,517 -1,188	-1%	-$22.4K	﹤0.01%	1777
2025 Q3	$1.49M	Buy	80,705 +1,869	+2%	+$30.5K	﹤0.01%	1742
2025 Q2	$1.22M	Sell	78,836 -4,939	-6%	-$76.5K	﹤0.01%	1802
2025 Q1	$1.36M	Buy	83,775 +13,147	+19%	+$226K	﹤0.01%	1625
2024 Q4	$1.13M	Sell	70,628 -540	-0.8%	-$9.58K	﹤0.01%	1765
2024 Q3	$1.32M	Buy	71,168 +1,717	+2%	+$32K	﹤0.01%	1648
2024 Q2	$1.21M	Sell	69,451 -4,506	-6%	-$75.2K	﹤0.01%	1629
2024 Q1	$1.25M	Buy	73,957 +4,116	+6%	+$70.1K	﹤0.01%	1583
2023 Q4	$1.16M	Sell	69,841 -9,131	-12%	-$140K	﹤0.01%	1553
2023 Q3	$1.23M	Buy	78,972 +3,548	+5%	+$59.2K	0.01%	1432
2023 Q2	$1.29M	Buy	75,424 +2,715	+4%	+$47.1K	0.01%	1441
2023 Q1	$1.28M	Buy	72,709 +474	+0.7%	+$8.62K	0.01%	1406
2022 Q4	$1.3M	Buy	72,235 +6,775	+10%	+$126K	0.01%	1342
2022 Q3	$1.13M	Buy	65,460 +2,458	+4%	+$47K	0.01%	1389
2022 Q2	$1.18M	Buy	63,002 +2,116	+3%	+$41.8K	0.01%	1357
2022 Q1	$1.26M	Buy	60,886 +36,285	+147%	+$771K	0.01%	1415
2021 Q4	$585K	Sell	24,601 -716	-3%	-$17.8K	﹤0.01%	1975
2021 Q3	$647K	Sell	25,317 -2,144	-8%	-$56.4K	﹤0.01%	1846
2021 Q2	$707K	Buy	27,461 +4,241	+18%	+$105K	﹤0.01%	1789
2021 Q1	$567K	Buy	23,220 +3,098	+15%	+$75.5K	﹤0.01%	1817
2020 Q4	$479K	Buy	20,122 +3,695	+22%	+$80.3K	﹤0.01%	1793
2020 Q3	$339K	Sell	16,427 -8,422	-34%	-$178K	﹤0.01%	1857
2020 Q2	$530K	Buy	24,849 +13,290	+115%	+$271K	﹤0.01%	1514
2020 Q1	$206K	Buy	+11,559	New	+$228K	﹤0.01%	1913
2015 Q4	–	Sell	-7,995	Closed	-$221K	–	1598
2015 Q3	$221K	Buy	+7,995	New	+$272K	0.01%	1200
2013 Q3	–	Sell	-12,778	Closed	-$287K	–	1215
2013 Q2	$287K	Buy	+12,778	New	+$272K	0.01%	779

Other funds holding HQH

ZCP

Z3 Capital Partners Richmond, Virginia $476M AUM

SIC

Samalin Investment Counsel Chappaqua, New York $320M AUM 20.87% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

SAM

Smith Asset Management Chiefland, Florida $127M AUM 5.85% 1-Year Est. Return

NAS

NWF Advisory Services Los Angeles, California $1.06B AUM 48.27% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

SCM

Sage Capital Management Stockton, New Jersey $256M AUM 29.76% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

TCM

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

Cambridge Investment Research Advisors's HQH Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its abrdn Healthcare Investors (HQH) stake by 5.6% in Q2 2026, buying an estimated $91.2K and bringing the position to 87,280 shares worth $1.92M. The position accounts for ﹤0.01% of the portfolio, ranked #1602.

Cambridge Investment Research Advisors first reported a position in HQH in Q2 2013 and has held it in 28 quarters since. 45 funds tracked by Wall St. Rank hold HQH as of Q2 2026.

Cambridge Investment Research Advisors held 87,280 shares of abrdn Healthcare Investors worth $1.92M as of Q2 2026.
Cambridge Investment Research Advisors bought 4,629 abrdn Healthcare Investors shares in Q2 2026, an estimated $91.2K.
abrdn Healthcare Investors made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1602 holding.
Cambridge Investment Research Advisors first reported a position in abrdn Healthcare Investors in Q2 2013 and has held it in 28 quarters since.
45 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.